1403 related articles for article (PubMed ID: 27161065)
1. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
3. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
[TBL] [Abstract][Full Text] [Related]
4. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
[TBL] [Abstract][Full Text] [Related]
5. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
[TBL] [Abstract][Full Text] [Related]
7. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
8. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
[TBL] [Abstract][Full Text] [Related]
11. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.
Hilario A; Hernandez-Lain A; Sepulveda JM; Lagares A; Perez-Nuñez A; Ramos A
Neurocirugia (Astur : Engl Ed); 2019; 30(1):11-18. PubMed ID: 30143443
[TBL] [Abstract][Full Text] [Related]
12. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
[TBL] [Abstract][Full Text] [Related]
16. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
Falk A; Fahlström M; Rostrup E; Berntsson S; Zetterling M; Morell A; Larsson HB; Smits A; Larsson EM
Neuroradiology; 2014 Dec; 56(12):1031-8. PubMed ID: 25204450
[TBL] [Abstract][Full Text] [Related]
17. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume.
Taoka T; Kawai H; Nakane T; Hori S; Ochi T; Miyasaka T; Sakamoto M; Kichikawa K; Naganawa S
Magn Reson Imaging; 2016 Sep; 34(7):896-901. PubMed ID: 27109485
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
[TBL] [Abstract][Full Text] [Related]
19. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.
Nguyen TB; Cron GO; Perdrizet K; Bezzina K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Sinclair J; Thornhill RE; Foottit C; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2017-22. PubMed ID: 26228886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
